PT  - JOURNAL ARTICLE
AU  - Akshay Nair
AU  - Adeel Razi
AU  - Sarah Gregory
AU  - Robb R. Rutledge
AU  - Geraint Rees
AU  - Sarah J Tabrizi
TI  - Imbalanced basal ganglia connectivity is associated with motor deficits and apathy in Huntington’s disease
AID  - 10.1101/2021.07.01.21259448
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.07.01.21259448
4099  - http://medrxiv.org/content/early/2021/07/06/2021.07.01.21259448.short
4100  - http://medrxiv.org/content/early/2021/07/06/2021.07.01.21259448.full
AB  - The gating of movement depends on activity within the cortico-striato-thalamic loops. Within these loops, emerging from the cells of the striatum, run two opponent pathways – the direct and indirect basal ganglia pathway. Both are complex and polysynaptic but the overall effect of activity within these pathways is thought to encourage and inhibit movement respectively. In Huntington’s disease (HD), the preferential early loss of striatal neurons forming the indirect pathway is thought to lead to disinhibition giving rise to the characteristic motor features of the condition. But early HD is also associated with apathy, a loss of motivation and failure to engage in goal-directed movement. We hypothesised that in HD, motor signs and apathy may be selectively correlated with indirect and direct pathway dysfunction respectively. We used spectral dynamic casual modelling of resting state fMRI data to model effective connectivity in a model of these cortico-striatal pathways. We tested both of these hypotheses in vivo for the first time in a large cohort of patients with prodromal HD. Using an advanced approach at the group level by combining Parametric Empirical Bayes and Bayesian Model Reduction procedure to generate large number of competing models and compare them by using Bayesian model comparison. With this automated Bayesian approach, associations between clinical measures and connectivity parameters emerge de novo from the data. We found very strong evidence (posterior probability > 0.99) to support both of our hypotheses. Firstly, more severe motor signs in HD were associated with altered connectivity in the indirect pathway components of our model and, by comparison, loss of goal-direct behaviour or apathy, was associated with changes in the direct pathway component. The empirical evidence we provide here is demonstrates that imbalanced basal ganglia connectivity may play an important role in the pathogenesis of some of commonest and disabling features of HD and may have important implications for therapeutics.Competing Interest StatementThe authors have declared no competing interest.Funding StatementA.N. is supported by the Leonard Wolfson Experimental Neurology Centre (Award: 525369). A.R. is funded by the Australian Research Council (Ref s: DE170100128 and DP200100757) and Australian National Health and Medical Research Council Investigator Grant (Ref: 1194910)." S.G. is supported by a Wellcome Trust Collaborative Award (200181/Z/15/Z). R.B.R. is supported by a Medical Research Council Career Development Award (MR/N02401X/1) and a NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation, P&S Fund. The Max Planck UCL Centre is a joint initiative supported by UCL and the Max Planck Society. The Wellcome Centre for Human Neuroimaging is supported by core funding from the Wellcome Trust (203147/Z/16/Z). G.R. receives grant funding from the Wellcome Trust. S.J.T. receives grant funding for her research from the Medical Research Council UK, the Wellcome Trust, the Rosetrees Trust, Takeda Pharmaceuticals, NIHR North Thames Local Clinical Research Network, UK Dementia Research Institute, Wolfson Foundation for Neurodegeneration and the CHDI Foundation. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:1. Joint REC for the National Hospital for Neurology and Neurosurgery and Institute of Neurology (07/H0716/47) - Approved 23rd July 2007. 2. Group Hospitalier Pitie-Salpetriere Ethic Committee (2007-A00772-51) - Approved 24th August 2007 3. Medical ethics committee Leiden University Medical Center (P07.142/Nv/nv) - approved October 2007 4. University of British Columbia, Clinical Research Ethics Board (H07-01759) - amendment approved Feb 2011All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yeson reasonable request